We did not provide further information on patients with pathological grade 4 astrocytoma, specifically IDH‐mutant glioblastoma, or patients with molecular grade 4 astrocytoma with CDKN2A/B homozygous deletion. The gene discussed is CDKN2A; the disease is astrocytoma (excluding glioblastoma).